outfox

Corporate insiders · SEC Form 4

What corporate insiders disclosed

Search 3,090 reported purchases and sales by company, ticker or reporting owner. Open the original filing behind every record.

Collection dates, coverage and reported prices

Searchable, source-checked disclosures from the collected filing windows below. History is still being added: gaps between windows and uncollected filings are not evidence of no trading. Issuer directories can differ between collections. Only non-derivative purchases and sales are shown; awards, exercises, gifts, holdings and derivatives are excluded. Unresolved amendments hold the affected issuer. Prices may be weighted averages or unspecified. This is not a complete YTD or current-portfolio view, and it is not used as complete-period input to homepage rankings. Historical rows retain their successful source-import interpretation and manifest hashes; their original XML was not freshly replayed for this release. The recent collection was replayed from archived SEC XML.

379 issuers held for correction review. 16,548 source rows excluded from this purchase/sale view.

  • Filed 2026-01-01–2026-01-02: 744 of 744 enumerated filings collected
  • Filed 2026-01-03–2026-01-04: 0 of 0 enumerated filings collected
  • Filed 2026-01-05–2026-01-06: 3,750 of 4,401 enumerated filings collected
  • Filed 2026-03-18–2026-03-19: 196 of 1,446 enumerated filings collected
  • Filed 2026-03-20–2026-03-21: 491 of 491 enumerated filings collected
  • Filed 2026-03-22–2026-03-23: 658 of 658 enumerated filings collected
  • Filed 2026-03-24–2026-03-25: 1,133 of 1,133 enumerated filings collected
  • Filed 2026-03-26–2026-03-27: 887 of 887 enumerated filings collected
  • Filed 2026-03-28–2026-03-29: 0 of 0 enumerated filings collected
  • Filed 2026-10-16–2026-10-16: 452 of 452 enumerated filings collected

Reported purchases and sales

Collected disclosures filed 2026-01-01–2026-10-16. Collection gaps remain. Filing dates are not execution dates.

2,545 matching source rows · Page 1 of 102.

WSM · Reported sale

WILLIAMS SONOMA INC · Common Stock

Finucane Anne A.

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
780
Reported price per share
252.12

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: Sale of shares pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 16, 2026.

F2: Reflects the weighted average price as the shares were sold in multiple transactions. The per share transaction price ranged from $252.02 to $252.78. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price as the shares were sold in multiple transactions. The per share transaction price ranged from $253.08 to $253.14. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

WSM · Reported sale

WILLIAMS SONOMA INC · Common Stock

Finucane Anne A.

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
14
Reported price per share
253.11

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: Sale of shares pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 16, 2026.

F2: Reflects the weighted average price as the shares were sold in multiple transactions. The per share transaction price ranged from $252.02 to $252.78. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price as the shares were sold in multiple transactions. The per share transaction price ranged from $253.08 to $253.14. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

QCOM · Reported sale

QUALCOMM INC/DE · Common Stock

CHAPLIN ANN C — EVP, GenCounsel&CorpSecretary

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
1827
Reported price per share
174.75

Price basis: Source-reported numeric price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.

F2: Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis.

F3: These Restricted Stock Units (and allocable dividend equivalents) vest in equal one-third amounts on October 15, 2025, 2026 and 2027.

Inspect original SEC filing ↗

SIG · Reported sale

SIGNET JEWELERS LTD · Common Shares, par value $0.18

Ptak Stash — * See Remarks

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
405
Reported price per share
120

Price basis: Source-reported numeric price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Filing remarks: Chief Legal, Compliance and Risk Officer

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into in good faith by the Reporting Person on April 7, 2026 for investment diversification purposes.

F2: Includes 6,442.63 restricted stock units which are subject to certain vesting and forfeiture provisions.

Inspect original SEC filing ↗

SARO · Reported sale

StandardAero, Inc. · Common Stock

Kaplan Michael L. — Chief Legal Officer

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
780
Reported price per share
21.24

Price basis: Source-reported numeric price. Ownership: direct.

Filing-level trading-plan indicator: Not indicated.

Filing remarks: Exhibit 24.1 - Power of Attorney

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2: The sale reported herein represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.

F3: The RSUs vest in three equal annual installments beginning on October 15, 2026.

Inspect original SEC filing ↗

BEAM · Reported sale

Beam Therapeutics Inc. · Common Stock

Evans John M. — CEO

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
25000
Reported price per share
23.9838

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2026.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.23 to $23.84, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.66 to $24.56, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: On July 13, 2018, the Reporting Person was granted an option to purchase 539,645 shares of common stock, which vested as to 25% of the underlying shares on January 8, 2019 and in 36 equal monthly installments thereafter.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

PEW · Reported sale

GrabAGun Digital Holdings Inc. · Common Stock

Nemati Marc A. — President and CEO

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
4108
Reported price per share
1.8502

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: Each restricted stock unit represents a contingent right to receive without payment one share of common stock of the Issuer.

F2: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of shares related to the restricted stock units that vested on October 15, 2026. The "sell to cover" transactions were effected pursuant to a Rule 10b5-1 trading plan and do not represent discretionary trades by the Reporting Person.

F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.85 to $1.89 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

F4: On September 29, 2025, the Reporting Person was granted 200,000 restricted stock units that vest in 12 equal quarterly increments commencing on July 15, 2025, with the first quarterly vesting occurring on October 15, 2025.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

PEW · Reported sale

GrabAGun Digital Holdings Inc. · Common Stock

Vittitow Matthew W. — Chief Operating Officer

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
2057
Reported price per share
1.8502

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: Each restricted stock unit represents a contingent right to receive without payment one share of common stock of the Issuer.

F2: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of shares related to the restricted stock units that vested on October 15, 2026. The "sell to cover" transactions were effected pursuant to a Rule 10b5-1 trading plan and do not represent discretionary trades by the Reporting Person.

F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.85 to $1.89 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

F4: On September 29, 2025, the Reporting Person was granted 100,000 restricted stock units that vest in 12 equal quarterly increments, with the first quarterly increment vesting on October 15, 2025.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

STRR · Reported sale

Star Equity Holdings, Inc. · Series A Preferred Stock

Eberwein Jeffrey E. — Chief Executive Officer

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
1000
Reported price per share
9.16

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and assumed by Clear Street LLC, providing for the sale of shares of the Issuer's Series A Cumulative Perpetual Preferred Stock, par value $0.001 per share. Sales under the plan were permitted to begin on October 1, 2026, and the plan expires on October 1, 2028, unless terminated earlier.

F2: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.11 on October 14, 2026, $9.06 to $9.60 on October 15, 2026, and $9.16 to $9.24 on October 16, 2026. The Reporting Person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold.

F3: Includes 6,257 shares of restricted stock credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Mr. Eberwein has elected to receive fifty percent of his base salary in the form of such restricted stock. Each share of restricted stock shall vest upon the first anniversary of the grant date and represents the right to receive, at settlement, one share of common stock.

F4: Includes (i) 23,852 shares of restricted stock and (ii) 6,750 RSUs credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated; and (iii) 1,106,757 shares of common stock. Excludes 2,000 shares indirectly owned in contributory 401(k) and IRA accounts. Each share of restricted stock and each RSU represents the right to receive, at settlement, one share of common stock.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

ODC · Reported sale

Oil-Dri Corp of America · Common Stock

Ryan Amy

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
1100
Reported price per share
78.8

Price basis: Source-reported numeric price. Ownership: direct.

Filing-level trading-plan indicator: Not indicated.

Inspect original SEC filing ↗

PACS · Reported sale

PACS Group, Inc. · Common Stock

Murray Jason Hulse — Co-Founder, CEO & Chairman

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
8462
Reported price per share
47.61

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.

F2: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.075 to $46.065 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $46.08 to $47.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.075 to $48.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $48.08 to $48.15 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.14 to $47.89 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

LIFE · Reported sale

Ethos Technologies Inc. · Class A Common Stock

Colis Peter George — CEO and Secretary

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
34468
Reported price per share
37.68

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. The Class B Common Stock has no expiration.

F2: Includes shares issuable on settlement of restricted stock units.

F3: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026, and occurred pursuant to the pre-established terms of such plan rather than as a result of a discretionary decision by the Reporting Person to sell shares at that time.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.34 to $39.31 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.36 to $39.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.04 to $38.035 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.04 to $38.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.065 to $39.135 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.205 to $38.195 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.21 to $38.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: The shares are held by the Colis Zhan Family Trust (the "Trust"). The Reporting Person is a trustee of the Trust.

F12: Shares held by John N. Colis, not individually, but solely as Trustee of the Peter G. Colis Family Trust U/A/D 7/4/2021.

F13: Shares held by Cresset Trust Company, a South Dakota-charted public trust company solely as Trustee of the PGC Beta Trust U/A/D 10/18/2024.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

LIFE · Reported sale

Ethos Technologies Inc. · Class A Common Stock

Colis Peter George — CEO and Secretary

Transaction date
2026-10-16
Filed
2026-10-16
Reported shares
5532
Reported price per share
38.32

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. The Class B Common Stock has no expiration.

F2: Includes shares issuable on settlement of restricted stock units.

F3: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026, and occurred pursuant to the pre-established terms of such plan rather than as a result of a discretionary decision by the Reporting Person to sell shares at that time.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.34 to $39.31 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.36 to $39.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.04 to $38.035 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.04 to $38.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.065 to $39.135 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.205 to $38.195 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.21 to $38.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: The shares are held by the Colis Zhan Family Trust (the "Trust"). The Reporting Person is a trustee of the Trust.

F12: Shares held by John N. Colis, not individually, but solely as Trustee of the Peter G. Colis Family Trust U/A/D 7/4/2021.

F13: Shares held by Cresset Trust Company, a South Dakota-charted public trust company solely as Trustee of the PGC Beta Trust U/A/D 10/18/2024.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

CDNS · Reported sale

CADENCE DESIGN SYSTEMS INC · Common Stock

Cunningham Paul — Sr. Vice President

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
2000
Reported price per share
324.13

Price basis: Source-reported numeric price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted on 3/16/2026 by the Reporting Person.

F2: These options vested at a rate of 1/48th per month starting on March 25, 2021.

Inspect original SEC filing ↗

SIG · Reported sale

SIGNET JEWELERS LTD · Common Shares, par value $0.18

Ptak Stash — * See Remarks

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
1595
Reported price per share
120

Price basis: Source-reported numeric price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Filing remarks: Chief Legal, Compliance and Risk Officer

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into in good faith by the Reporting Person on April 7, 2026 for investment diversification purposes.

F2: Includes 6,442.63 restricted stock units which are subject to certain vesting and forfeiture provisions.

Inspect original SEC filing ↗

TTWO · Reported sale

TAKE TWO INTERACTIVE SOFTWARE INC · Common Stock

Siminoff Ellen F

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
167
Reported price per share
202.92

Price basis: Source-reported numeric price. Ownership: indirect.

Ownership as disclosed: By the D&E Living Trust

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: Sale of shares pursuant to a Rule 10b5-1 trading plan adopted by the D&E Living Trust and the EFS 2020 Irrevocable Trust on February 19, 2026.

F2: Shares held directly by the D&E Living Trust. The Reporting Person and David Siminoff serve as co-trustees and retain voting and dispositive power with respect to the shares held by the D&E Living Trust.

F3: Shares held directly by the EFS 2020 Irrevocable Trust. The Reporting Person serves as trustee and holds voting and dispositive power with respect to these shares.

Inspect original SEC filing ↗

TTWO · Reported sale

TAKE TWO INTERACTIVE SOFTWARE INC · Common Stock

Siminoff Ellen F

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
167
Reported price per share
202.92

Price basis: Source-reported numeric price. Ownership: indirect.

Ownership as disclosed: By the EFS 2020 Irrevocable Trust

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: Sale of shares pursuant to a Rule 10b5-1 trading plan adopted by the D&E Living Trust and the EFS 2020 Irrevocable Trust on February 19, 2026.

F2: Shares held directly by the D&E Living Trust. The Reporting Person and David Siminoff serve as co-trustees and retain voting and dispositive power with respect to the shares held by the D&E Living Trust.

F3: Shares held directly by the EFS 2020 Irrevocable Trust. The Reporting Person serves as trustee and holds voting and dispositive power with respect to these shares.

Inspect original SEC filing ↗

SRAD · Reported sale

Sportradar Group AG · Class A Ordinary Shares

MILLER MICHAEL CONNOLLY — Chief Legal Officer

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
1840
Reported price per share
12.0995

Price basis: Weighted average—not an individual execution price. Ownership: direct.

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2026.

F2: The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $11.74 to $12.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

UTHR · Reported sale

UNITED THERAPEUTICS Corp · Common Stock

ROTHBLATT MARTINE A — Chairperson & CEO

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
281
Reported price per share
540.4764

Price basis: Weighted average—not an individual execution price. Ownership: indirect.

Ownership as disclosed: by Trust

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.

F10: This transaction was executed in multiple trades at prices ranging from $547.38 to $548.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $548.39 to $549.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: This transaction was executed in multiple trades at prices ranging from $549.39 to $550.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: This transaction was executed in multiple trades at prices ranging from $550.42 to $551.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F14: This transaction was executed in multiple trades at prices ranging from $551.48 to $551.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F18: These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.

F19: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.

F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F3: This transaction was executed in multiple trades at prices ranging from $540.08 to $541.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $541.13 to $542.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $542.13 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $543.22 to $544.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $544.28 to $545.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: This transaction was executed in multiple trades at prices ranging from $545.34 to $546.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: This transaction was executed in multiple trades at prices ranging from $546.38 to $547.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

UTHR · Reported sale

UNITED THERAPEUTICS Corp · Common Stock

ROTHBLATT MARTINE A — Chairperson & CEO

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
1009
Reported price per share
549.756

Price basis: Weighted average—not an individual execution price. Ownership: indirect.

Ownership as disclosed: by Trust

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.

F10: This transaction was executed in multiple trades at prices ranging from $547.38 to $548.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $548.39 to $549.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: This transaction was executed in multiple trades at prices ranging from $549.39 to $550.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: This transaction was executed in multiple trades at prices ranging from $550.42 to $551.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F14: This transaction was executed in multiple trades at prices ranging from $551.48 to $551.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F18: These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.

F19: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.

F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F3: This transaction was executed in multiple trades at prices ranging from $540.08 to $541.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $541.13 to $542.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $542.13 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $543.22 to $544.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $544.28 to $545.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: This transaction was executed in multiple trades at prices ranging from $545.34 to $546.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: This transaction was executed in multiple trades at prices ranging from $546.38 to $547.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

UTHR · Reported sale

UNITED THERAPEUTICS Corp · Common Stock

ROTHBLATT MARTINE A — Chairperson & CEO

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
200
Reported price per share
550.716

Price basis: Weighted average—not an individual execution price. Ownership: indirect.

Ownership as disclosed: by Trust

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.

F10: This transaction was executed in multiple trades at prices ranging from $547.38 to $548.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $548.39 to $549.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: This transaction was executed in multiple trades at prices ranging from $549.39 to $550.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: This transaction was executed in multiple trades at prices ranging from $550.42 to $551.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F14: This transaction was executed in multiple trades at prices ranging from $551.48 to $551.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F18: These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.

F19: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.

F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F3: This transaction was executed in multiple trades at prices ranging from $540.08 to $541.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $541.13 to $542.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $542.13 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $543.22 to $544.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $544.28 to $545.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: This transaction was executed in multiple trades at prices ranging from $545.34 to $546.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: This transaction was executed in multiple trades at prices ranging from $546.38 to $547.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

UTHR · Reported sale

UNITED THERAPEUTICS Corp · Common Stock

ROTHBLATT MARTINE A — Chairperson & CEO

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
120
Reported price per share
551.5

Price basis: Weighted average—not an individual execution price. Ownership: indirect.

Ownership as disclosed: by Trust

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.

F10: This transaction was executed in multiple trades at prices ranging from $547.38 to $548.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $548.39 to $549.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: This transaction was executed in multiple trades at prices ranging from $549.39 to $550.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: This transaction was executed in multiple trades at prices ranging from $550.42 to $551.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F14: This transaction was executed in multiple trades at prices ranging from $551.48 to $551.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F18: These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.

F19: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.

F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F3: This transaction was executed in multiple trades at prices ranging from $540.08 to $541.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $541.13 to $542.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $542.13 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $543.22 to $544.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $544.28 to $545.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: This transaction was executed in multiple trades at prices ranging from $545.34 to $546.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: This transaction was executed in multiple trades at prices ranging from $546.38 to $547.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

UTHR · Reported sale

UNITED THERAPEUTICS Corp · Common Stock

ROTHBLATT MARTINE A — Chairperson & CEO

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
1163
Reported price per share
541.5859

Price basis: Weighted average—not an individual execution price. Ownership: indirect.

Ownership as disclosed: by Trust

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.

F10: This transaction was executed in multiple trades at prices ranging from $547.38 to $548.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $548.39 to $549.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: This transaction was executed in multiple trades at prices ranging from $549.39 to $550.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: This transaction was executed in multiple trades at prices ranging from $550.42 to $551.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F14: This transaction was executed in multiple trades at prices ranging from $551.48 to $551.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F18: These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.

F19: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.

F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F3: This transaction was executed in multiple trades at prices ranging from $540.08 to $541.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $541.13 to $542.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $542.13 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $543.22 to $544.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $544.28 to $545.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: This transaction was executed in multiple trades at prices ranging from $545.34 to $546.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: This transaction was executed in multiple trades at prices ranging from $546.38 to $547.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

UTHR · Reported sale

UNITED THERAPEUTICS Corp · Common Stock

ROTHBLATT MARTINE A — Chairperson & CEO

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
456
Reported price per share
542.6793

Price basis: Weighted average—not an individual execution price. Ownership: indirect.

Ownership as disclosed: by Trust

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.

F10: This transaction was executed in multiple trades at prices ranging from $547.38 to $548.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $548.39 to $549.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: This transaction was executed in multiple trades at prices ranging from $549.39 to $550.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: This transaction was executed in multiple trades at prices ranging from $550.42 to $551.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F14: This transaction was executed in multiple trades at prices ranging from $551.48 to $551.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F18: These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.

F19: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.

F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F3: This transaction was executed in multiple trades at prices ranging from $540.08 to $541.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $541.13 to $542.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $542.13 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $543.22 to $544.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $544.28 to $545.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: This transaction was executed in multiple trades at prices ranging from $545.34 to $546.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: This transaction was executed in multiple trades at prices ranging from $546.38 to $547.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗

UTHR · Reported sale

UNITED THERAPEUTICS Corp · Common Stock

ROTHBLATT MARTINE A — Chairperson & CEO

Transaction date
2026-10-15
Filed
2026-10-16
Reported shares
371
Reported price per share
543.3929

Price basis: Weighted average—not an individual execution price. Ownership: indirect.

Ownership as disclosed: by Trust

Filing-level trading-plan indicator: Indicated—not assigned to every row.

Source footnotes

Footnotes belong to the filing; numbered references identify the affected fields. They are not automatically assigned to every row.

F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.

F10: This transaction was executed in multiple trades at prices ranging from $547.38 to $548.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $548.39 to $549.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: This transaction was executed in multiple trades at prices ranging from $549.39 to $550.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: This transaction was executed in multiple trades at prices ranging from $550.42 to $551.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F14: This transaction was executed in multiple trades at prices ranging from $551.48 to $551.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

F18: These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.

F19: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.

F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

F3: This transaction was executed in multiple trades at prices ranging from $540.08 to $541.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $541.13 to $542.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $542.13 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $543.22 to $544.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $544.28 to $545.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: This transaction was executed in multiple trades at prices ranging from $545.34 to $546.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: This transaction was executed in multiple trades at prices ranging from $546.38 to $547.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Source and parsing caveats

price is weighted average

Inspect original SEC filing ↗